Literature DB >> 24893732

Apparent diffusion coefficient in glioblastoma with PNET-like components, a GBM variant.

Saad Ali1, Nancy M Joseph, Arie Perry, Ramon F Barajas, Soonmee Cha.   

Abstract

Glioblastoma (GBM) with primitive neuroectodermal tumor (PNET)-like (GBM-PNET) components is a rare variant of GBM. Recent studies describe PNET-like clinical behavior in these patients-with significantly increased propensity for CSF dissemination and a benefit of "PNET-like" chemotherapy. The imaging appearance of GBM-PNET is not well-described and given areas of marked cellularity in the PNET components one might expect significantly reduced diffusion on MRI. The purpose of this study is to quantitatively evaluate the diffusion characteristics in GBM-PNET and compare them with conventional GBMs. Nine patients with surgical specimens yielding GBM-PNET were identified from the UCSF Pathology files. MR images of these patients were reviewed retrospectively. DWI (diffusion-weighted imaging) sequences were analyzed with multiple regions of interests placed within the tumor, and ADC (apparent diffusion coefficient) values were measured. Results were compared to previously published ADC values in pathology-proven conventional GBM cases from our institution. Reduced ADC was seen in GBM-PNET (mean 581 × 10(-6) mm(2)/s, range 338-817) compared to previously published mean of 1,030 × 10(-6) mm(2)/s in the enhancing components of conventional GBMs. We report substantially reduced ADC values in GBM-PNETs compared to conventional GBMs. If demonstrated in a larger sample, when areas of marked reduced diffusion are seen in a suspected GBM, MRI may appropriately direct tissue sampling and can advocate a thorough search for PNET-like components on histopathology. These patients may have a higher chance of developing CSF dissemination and may benefit from "PNET-like" platinum-based chemotherapy.

Entities:  

Mesh:

Year:  2014        PMID: 24893732     DOI: 10.1007/s11060-014-1485-3

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  24 in total

1.  Usefulness of diffusion-weighted MRI with echo-planar technique in the evaluation of cellularity in gliomas.

Authors:  T Sugahara; Y Korogi; M Kochi; I Ikushima; Y Shigematu; T Hirai; T Okuda; L Liang; Y Ge; Y Komohara; Y Ushio; M Takahashi
Journal:  J Magn Reson Imaging       Date:  1999-01       Impact factor: 4.813

2.  Minimum apparent diffusion coefficients in the evaluation of brain tumors.

Authors:  Omer Kitis; Hakan Altay; Cem Calli; Nilgun Yunten; Taner Akalin; Taskin Yurtseven
Journal:  Eur J Radiol       Date:  2005-09       Impact factor: 3.528

3.  Comparison of CSF cytology and spinal magnetic resonance imaging in the detection of leptomeningeal disease in pediatric medulloblastoma or primitive neuroectodermal tumor.

Authors:  M Fouladi; A Gajjar; J M Boyett; A W Walter; S J Thompson; T E Merchant; J J Jenkins; J W Langston; A Liu; L E Kun; R L Heideman
Journal:  J Clin Oncol       Date:  1999-10       Impact factor: 44.544

4.  Apparent diffusion coefficients for differentiation of cerebellar tumors in children.

Authors:  Z Rumboldt; D L A Camacho; D Lake; C T Welsh; M Castillo
Journal:  AJNR Am J Neuroradiol       Date:  2006 Jun-Jul       Impact factor: 3.825

5.  MRI apparent diffusion coefficient reflects histopathologic subtype, axonal disruption, and tumor fraction in diffuse-type grade II gliomas.

Authors:  Inas S Khayal; Scott R Vandenberg; Kenneth J Smith; Colleen P Cloyd; Susan M Chang; Soonmee Cha; Sarah J Nelson; Tracy R McKnight
Journal:  Neuro Oncol       Date:  2011-08-24       Impact factor: 12.300

6.  Paediatric PNET: pre-surgical MRI features.

Authors:  A Chawla; J V Emmanuel; W T Seow; J Lou; H E Teo; C C T Lim
Journal:  Clin Radiol       Date:  2007-01       Impact factor: 2.350

Review 7.  Recent advances in embryonal tumours of the central nervous system.

Authors:  Chitra Sarkar; Prabal Deb; Mehar Chand Sharma
Journal:  Childs Nerv Syst       Date:  2005-01-29       Impact factor: 1.475

8.  Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III study.

Authors:  P M Zeltzer; J M Boyett; J L Finlay; A L Albright; L B Rorke; J M Milstein; J C Allen; K R Stevens; P Stanley; H Li; J H Wisoff; J R Geyer; P McGuire-Cullen; J A Stehbens; S B Shurin; R J Packer
Journal:  J Clin Oncol       Date:  1999-03       Impact factor: 44.544

9.  Malignant gliomas with primitive neuroectodermal tumor-like components: a clinicopathologic and genetic study of 53 cases.

Authors:  Arie Perry; C Ryan Miller; Meena Gujrati; Bernd W Scheithauer; Sandro Casavilca Zambrano; Sarah C Jost; Ravi Raghavan; Jiang Qian; Elizabeth J Cochran; Jason T Huse; Eric C Holland; Peter C Burger; Marc K Rosenblum
Journal:  Brain Pathol       Date:  2008-04-29       Impact factor: 6.508

10.  Survival and prognostic factors following radiation and/or chemotherapy for primitive neuroectodermal tumors of the pineal region in infants and children: a report of the Childrens Cancer Group.

Authors:  R I Jakacki; P M Zeltzer; J M Boyett; A L Albright; J C Allen; J R Geyer; L B Rorke; P Stanley; K R Stevens; J Wisoff
Journal:  J Clin Oncol       Date:  1995-06       Impact factor: 44.544

View more
  6 in total

1.  Glioblastoma with primitive neuronal component: A case report and considerations of fluorescence-guided surgery.

Authors:  Juan Francisco Sánchez-Ortega; Jesús Aguas-Valiente; Patricia Sota-Ochoa; Juan Calatayud-Pérez
Journal:  Surg Neurol Int       Date:  2020-07-04

2.  CDK4, CDK6, cyclin D1, p16(INK4a) and EGFR expression in glioblastoma with a primitive neuronal component.

Authors:  Guiyan Xu; Jian Yi Li
Journal:  J Neurooncol       Date:  2017-11-17       Impact factor: 4.130

3.  Therapeutic approach in glioblastoma multiforme with primitive neuroectodermal tumor components: Case report and review of the literature.

Authors:  Arsela Prelaj; Sara Elena Rebuzzi; Giovanni Caffarena; Julio Rodrigo Giròn Berrìos; Silvia Pecorari; Carmela Fusto; Alessandro Caporlingua; Federico Caporlingua; Annamaria Di Palma; Fabio Massimo Magliocca; Maurizio Salvati; Silverio Tomao; Vincenzo Bianco
Journal:  Oncol Lett       Date:  2018-02-21       Impact factor: 2.967

4.  Craniospinal irradiation with concomitant and adjuvant temozolomide--a feasibility assessment of toxicity in patients with glioblastoma with a PNET component.

Authors:  Ben O'Leary; Henry C Mandeville; Naomi Fersht; Francesca Solda; Julie Mycroft; Stergios Zacharoulis; Sucheta Vaidya; Frank Saran
Journal:  J Neurooncol       Date:  2016-02-02       Impact factor: 4.130

5.  A Rare Manifestation of a Presumed Non-Osteophilic Brain Neoplasm: Extensive Axial Skeletal Metastases From Glioblastoma With Primitive Neuronal Components.

Authors:  Tianhua Rong; Wanjing Zou; Xiaoguang Qiu; Wei Cui; Duo Zhang; Bingxuan Wu; Zhuang Kang; Wenbin Li; Baoge Liu
Journal:  Front Oncol       Date:  2021-11-02       Impact factor: 6.244

6.  Malignant glioma-primitive neuroectodermal tumor recurring as PNET-like only subdural collection: Case report.

Authors:  Anthony M Alvarado; Michael E Salacz; Roukoz B Chamoun
Journal:  Surg Neurol Int       Date:  2017-10-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.